Order Article Reprints

Lang A, Oehler D, Benkhoff M, Reinders Y, Barcik M, Shahrjerdi K, Kaldirim M, Sickmann A, Dannenberg L, Polzin A, et al. Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction. Biomedicines. 2024; 12(10):2368. https://doi.org/10.3390/biomedicines12102368

Lang, Alexander, Daniel Oehler, Marcel Benkhoff, Yvonne Reinders, Maike Barcik, Khatereh Shahrjerdi, Madlen Kaldirim, Albert Sickmann, Lisa Dannenberg, Amin Polzin, and et al. 2024. "Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction" Biomedicines 12, no. 10: 2368. https://doi.org/10.3390/biomedicines12102368

Lang, A., Oehler, D., Benkhoff, M., Reinders, Y., Barcik, M., Shahrjerdi, K., Kaldirim, M., Sickmann, A., Dannenberg, L., Polzin, A., Pfeiler, S., Kelm, M., Grandoch, M., Jung, C., & Gerdes, N. (2024). Mitochondrial Creatine Kinase 2 (Ckmt2) as a Plasma-Based Biomarker for Evaluating Reperfusion Injury in Acute Myocardial Infarction. Biomedicines, 12(10), 2368. https://doi.org/10.3390/biomedicines12102368